This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deng, X.
Right arrow Articles by May, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deng, X.
Right arrow Articles by May, W. S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, June 2006, p. 4421-4434, Vol. 26, No. 12
0270-7306/06/$08.00+0     doi:10.1128/MCB.01647-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Bcl2's Flexible Loop Domain Regulates p53 Binding and Survival

Xingming Deng, Fengqin Gao, Tammy Flagg, Jessica Anderson, and W. Stratford May*

UF Shands Cancer Center, Department of Medicine, University of Florida Health Science Center, Gainesville, Florida 32610-0232

Received 24 August 2005/ Returned for modification 23 October 2005/ Accepted 17 March 2006

p53 not only functions as a transcription factor but also has a direct, apoptogenic role at the mitochondria. We have discovered that DNA damage-induced p53-Bcl2 binding is associated with decreased Bcl2-Bax interaction and increased apoptotic cell death in a mechanism regulated by Bcl2's flexible loop regulatory domain (FLD), since purified p53 protein can disrupt the Bcl2/Bax complex by directly binding to a negative regulatory region of the FLD (amino acids [aa] 32 to 68). Deletion of the negative regulatory region ({Delta}32-68) abolishes Bcl2-p53 binding and enhances Bcl2's antiapoptotic function. Conversely, removal of a positive regulatory region (aa 69 to 87) of the FLD, which contains the Bcl2 phosphorylation site(s) T69, S70, and S87, enhances Bcl2-p53 binding and significantly abrogates Bcl2's survival activity. The phospho-mimetic T69E/S70E/S87E (EEE) but not the nonphosphorylatable T69A/S70A/S87A (AAA) Bcl2 mutant displays a reduced capacity to bind p53 and potently inhibits p53-induced cytochrome c release from isolated mitochondria. Furthermore, the FLD-only aa32-87 and aa32-68 peptides but not the aa69-87 peptide can directly bind p53 in vitro. p53-induced cytochrome c release occurs through a mechanism involving Bax's integral insertion into the outer mitochondrial membrane. Either DNA damage to cells or expression of p53 selectively targeted to the mitochondria results in Bcl2-p53 binding followed by exposure of Bcl2's BH3 domain in association with inactivation of Bcl2's antiapoptotic function, indicating a conformational change in Bcl2 can occur upon direct ligation of p53. Thus, Bcl2's FLD contains both positive and negative regulatory regions which functionally regulate Bcl2's antiapoptotic activity by affecting Bax or p53 binding.

* Corresponding author. Mailing address: University of Florida Shands Cancer Center, 1600 SW Archer Rd., Medical Science Building, N505, P.O. Box 100232, Gainesville, FL 32610-0232. Phone: (352) 273-8010. Fax: (352) 846-1193. E-mail: smay{at}ufscc.ufl.edu.

Molecular and Cellular Biology, June 2006, p. 4421-4434, Vol. 26, No. 12
0270-7306/06/$08.00+0     doi:10.1128/MCB.01647-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Johnson, N. A., Savage, K. J., Ludkovski, O., Ben-Neriah, S., Woods, R., Steidl, C., Dyer, M. J. S., Siebert, R., Kuruvilla, J., Klasa, R., Connors, J. M., Gascoyne, R. D., Horsman, D. E. (2009). Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 114: 2273-2279 [Abstract] [Full Text]  
  • Yamaguchi, H., Woods, N. T., Piluso, L. G., Lee, H.-H., Chen, J., Bhalla, K. N., Monteiro, A., Liu, X., Hung, M.-C., Wang, H.-G. (2009). p53 Acetylation Is Crucial for Its Transcription-independent Proapoptotic Functions. J. Biol. Chem. 284: 11171-11183 [Abstract] [Full Text]  
  • Deng, X., Gao, F., May, W. S. (2009). Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding. Blood 113: 422-428 [Abstract] [Full Text]  
  • Sagulenko, V., Muth, D., Sagulenko, E., Paffhausen, T., Schwab, M., Westermann, F. (2008). Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death. Carcinogenesis 29: 1869-1877 [Abstract] [Full Text]  
  • Thompson, J., Winoto, A. (2008). During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. JEM 205: 1029-1036 [Abstract] [Full Text]  
  • Zhao, J., Gao, F., Zhang, Y., Wei, K., Liu, Y., Deng, X. (2008). Bcl2 Inhibits Abasic Site Repair by Down-regulating APE1 Endonuclease Activity. J. Biol. Chem. 283: 9925-9932 [Abstract] [Full Text]  
  • Tucker, C. A., Kapanen, A. I., Chikh, G., Hoffman, B. G., Kyle, A. H., Wilson, I. M., Masin, D., Gascoyne, R. D., Bally, M., Klasa, R. J. (2008). Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-{kappa}B, p53, bax, and p27 levels. Molecular Cancer Therapeutics 7: 749-758 [Abstract] [Full Text]  
  • Reed, J. C. (2008). Bcl-2-family proteins and hematologic malignancies: history and future prospects. Blood 111: 3322-3330 [Abstract] [Full Text]  
  • Hou, Y., Gao, F., Wang, Q., Zhao, J., Flagg, T., Zhang, Y., Deng, X. (2007). Bcl2 Impedes DNA Mismatch Repair by Directly Regulating the hMSH2-hMSH6 Heterodimeric Complex. J. Biol. Chem. 282: 9279-9287 [Abstract] [Full Text]  
  • Yang, M., Wu, S., Su, X., May, W. S. (2006). JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity. Blood 108: 4136-4145 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»